TMX Newsfile Pharmaceuticals News Releases

Defence Therapeutics Announces Grant of Restricted Stock Units

Fri, 24 Apr 2026 18:30:00 -0400

Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, wishes to announce that the board of directors of the Company approved the grant of 200,000 incentive restricted stock units ("RSUs") to Mr. Sebastien Plouffe, CEO and Director of the Company, vesting immediately. Each RSU entitles the holder thereof to receive one...

Herbal Dispatch Reports Q4 2025 Gross Sales of $6.2 Million, Achieves Positive Adjusted EBITDA, and Reports Full Year Gross Sales of $16.5 Million

Fri, 24 Apr 2026 03:01:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), announces its financial results for the fourth quarter and year ended December 31, 2025.Q4 2025 HIGHLIGHTSGross sales of $6.2 million, representing a 115% increase compared to $2.9 million in Q4 2024Net revenue of $4.1 million (excluding excise taxes), up from $2.3 million in Q4 2024Adjusted EBITDA of $0.1 million, compared to $(0.6)...

Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing

Thu, 23 Apr 2026 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that further to its press release dated March 16, 2026, it intends to complete a portion of its previously announced offering of common shares (the "Offering") in Canada pursuant to the Listed Issuer Financing Exemption contained in Part A of...

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

Thu, 23 Apr 2026 07:00:00 -0400

King of Prussia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will provide an overview of the Company's INTASYL siRNA platform and discuss recent clinical progress and priorities, followed by a live...

Herbal Dispatch Welcomes the Honourable Herb Dhaliwal as Full-Time Chairman

Thu, 23 Apr 2026 03:01:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce the appointment of the Honourable Herb Dhaliwal, PC, as a full-time Board Member and Chairman of the Board.The Honourable Herb Dhaliwal, brings a wealth of experience in public service, business, and leadership to Herbal Dispatch. Mr. Dhaliwal is a former...

Unbuzzd Wellness Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

Wed, 22 Apr 2026 09:01:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM ("unbuzzd") — the scientifically-proven and game-changing beverage proven to accelerate alcohol metabolism, restore mental clarity and reduce hangover symptoms, is pleased to announce the appointment of Mr. Richard Buzbuzian as Chief Executive Officer. This marks a pivotal milestone in the Company's commercialization strategy. With the functional...

PreveCeutical Announces Non-Brokered Private Placement

Wed, 22 Apr 2026 03:00:00 -0400

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 40,000,000 units (each, a "Unit") in the capital of the Company at a price of $0.025 per Unit for gross proceeds of up to $1,000,000. Each Unit consists...

Gregory Esemplare Appointed Chief Operating Officer of HarmonyRx

Tue, 21 Apr 2026 08:25:00 -0400

New York, New York--(Newsfile Corp. - April 21, 2026) - HarmonyRx today announced the appointment of Gregory Esemplare as Chief Operating Officer (COO).In this role, Greg will oversee operations across the organization, with a focus on driving alignment, enhancing execution and supporting continued growth in pharmacy benefits.Greg brings extensive experience in healthcare services, pharmacy benefits and client-focused operations. He previously served in a senior leadership position at HarmonyRx,...

PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness

Tue, 21 Apr 2026 08:00:00 -0400

Company believes supportive U.S. policy momentum may strengthen the strategic value of its ketamine patch, KetaVault™ platform, retained ketamine programs, and prior FDA-approved ketamine ANDA transactionToronto, Ontario--(Newsfile Corp. - April 21, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a specialty pharmaceutical company, today announced that it believes the recent U.S. executive order, "Accelerating Medical Treatments for Serious Mental...

Herbal Dispatch Announces Receipt of U.S. DTC Eligibility and Engagement of Market Maker

Tue, 21 Apr 2026 03:01:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce that the Company's common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC").DTC eligibility significantly enhances accessibility for U.S.-based investors by facilitating electronic trading, book-entry...